- Home
- IH vs ELDN Comparison
IH vs ELDN Comparison
Compare IH & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- ELDN
- Stock Information
- Founded
- IH 1996
- ELDN 2004
- Country
- IH China
- ELDN United States
- Employees
- IH N/A
- ELDN N/A
- Industry
- IH Other Consumer Services
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- IH Real Estate
- ELDN Health Care
- Exchange
- IH Nasdaq
- ELDN Nasdaq
- Market Cap
- IH 146.3M
- ELDN 164.1M
- IPO Year
- IH 2020
- ELDN N/A
- Fundamental
- Price
- IH $2.68
- ELDN $3.64
- Analyst Decision
- IH
- ELDN Strong Buy
- Analyst Count
- IH 0
- ELDN 2
- Target Price
- IH N/A
- ELDN $12.50
- AVG Volume (30 Days)
- IH 15.1K
- ELDN 1.4M
- Earning Date
- IH 09-18-2025
- ELDN 11-11-2025
- Dividend Yield
- IH 3.06%
- ELDN N/A
- EPS Growth
- IH N/A
- ELDN N/A
- EPS
- IH 0.29
- ELDN 0.21
- Revenue
- IH $123,215,612.00
- ELDN N/A
- Revenue This Year
- IH $39.02
- ELDN N/A
- Revenue Next Year
- IH N/A
- ELDN N/A
- P/E Ratio
- IH $9.71
- ELDN $16.41
- Revenue Growth
- IH N/A
- ELDN N/A
- 52 Week Low
- IH $1.47
- ELDN $2.32
- 52 Week High
- IH $3.60
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- IH 43.20
- ELDN 69.68
- Support Level
- IH $2.65
- ELDN $3.18
- Resistance Level
- IH $2.89
- ELDN $3.76
- Average True Range (ATR)
- IH 0.21
- ELDN 0.27
- MACD
- IH -0.02
- ELDN 0.06
- Stochastic Oscillator
- IH 6.71
- ELDN 83.06
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.